Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

We are very pleased to inform you that Dr. Marc A. Gauthier has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Early Career Investigator Award, acknowledging his outstanding contributions to our Society...

Dear CBS Members, As you are aware, the COVID-19 pandemic has caused numerous disruptions around the world, and scheduled conferences are being either postponed or canceled...

We are very pleased to inform you that Dr. Paul Santerre has been selected by the Board of Directors of the Canadian Biomaterials Society CBS as the next recipient of the CBS Lifetime Achievement Award , acknowledging his outstanding contributions to our Society...

CBS is pleased to offer travel awards to assist students and post-doctoral fellows who are CBS members to present their accepted oral or poster abstracts at the 11th World Biomaterials Congress this May in Glasgow, Scotland...

Orthopaedic surgical site infections affect over 100,000 people each year in North America1-2, with annual costs of over 10B and have been a major cause of surgical revision in total joint replacements1-2...

Adverse local tissue reactions to hip implants ALTRs are characterized by chronic inflammation, fibrosis and necrosis of the joints soft tissues, generating pain, swelling, increasing the risk of dislocation and failure of the reconstructive surgeries, thus reducing mobility with the subsequent detriment on the quality of life of patients 1 ...

Cardiovascular disease is the leading cause of mortality worldwide. In Canada, over 50 000 coronary artery bypass surgeries and percutaneous coronary interventions are performed each year...

Tendon and ligament reconstruction account for 30 billion per year in the USA alone1. Current gold standard is autograft-based, which limits supply and causes donor site morbidity...

Tumors contain heterogeneous and dynamic populations of cells that do not all display the fast- proliferating properties that traditional chemotherapies target...